Book a Meeting

Anti-Discoidin Domain Receptor 2 Antibody, Non-Fucosylated (9M58) (CAT#: BioBet-769ZP) Datasheet

Target
Discoidin Domain Receptor 2
Isotype
IgG1
Description
Anti-Discoidin Domain Receptor 2 Antibody, Non-Fucosylated (BioBet-769ZP) is a human monoclonal IgG1 antibody against Discoidin Domain Receptor 2. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Cancer; Solid Tumor
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Discoidin Domain Receptor 2 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
DDR2
Full Name
discoidin domain receptor tyrosine kinase 2
Background
receptor tyrosine kinases (RTKs) play a key role in the communication of cells with their microenvironment. These molecules are involved in the regulation of cell growth, differentiation, and metabolism. In several cases the biochemical mechanism by which RTKs transduce signals across the membrane has been shown to be ligand induced receptor oligomerization and subsequent intracellular phosphorylation. This autophosphorylation leads to phosphorylation of cytosolic targets as well as association with other molecules, which are involved in pleiotropic effects of signal transduction. RTKs have a tripartite structure with extracellular, transmembrane, and cytoplasmic regions. This gene encodes a member of a novel subclass of RTKs and contains a distinct extracellular region encompassing a factor VIII-like domain. Alternative splicing in the 5 UTR results in multiple transcript variants encoding the same protein.
Alternative Names
DDR2; discoidin domain receptor tyrosine kinase 2; TKT; MIG20a; NTRKR3; TYRO10; discoidin domain-containing receptor 2; tyrosylprotein kinase; hydroxyaryl-protein kinase; discoidin domain receptor 2; tyrosine-protein kinase TYRO10; CD167 antigen-like family member B; cell migration-inducing protein 20; migration-inducing gene 16 protein; receptor protein-tyrosine kinase TKT; discoidin domain receptor family, member 2; neurotrophic tyrosine kinase receptor related 3; neurotrophic tyrosine kinase, receptor-related 3; discoidin domain-containing receptor tyrosine kinase 2
Gene ID
Cellular Localization
Plasma membrane
Involvement in Disease
Diseases associated with DDR2 include Spondylometaepiphyseal Dysplasia, Short Limb-Hand Type and Warburg-Cinotti Syndrome.
Related Pathways
Its related pathways are Degradation of the extracellular matrix and Activation of cAMP-Dependent PKA.
Function
Tyrosine kinases are involved in the regulation of tissue remodeling (PubMed: 30449416). It is the cell surface receptor of fibrillar collagen and regulates cell differentiation, extracellular matrix remodeling, cell migration and cell proliferation. It is necessary for normal bone development to regulate osteoblast differentiation and chondrocyte maturation through signal pathways involving MAP kinase, leading to the activation of the transcription factor RUNX2. By up-regulating collagenases MMP1, MMP2, MMP13, it regulates extracellular matrix remodeling and promotes cell migration and tumor cell invasion. Promote the migration and proliferation of fibroblasts, thereby promoting skin wound healing.
Post-translational modifications
1.Glycosylated 2.Modification sites at PhosphoSitePlus 3.Tyrosine phosphorylated in response to collagen binding. Phosphorylated by SRC; this is required for activation and subsequent autophosphorylation on additional tyrosine residues. Q16832-DDR2_HUMAN Glycosylation at Asn121, Asn213, Asn261, Asn280, and Asn372
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1
Antibody Clone
9M58
Host
Human
Species Reactivity
Human
Description
This is an antibody that specifically binds to an extracellular domain of human DDR2 and has a therapeutic effect on the solid tumor and cancer.
Antibody Indication
Cancer; Solid Tumor

Cancer; Solid Tumor

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.